Encyclopedia of Experiments: Neuroscience
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Transcript
To begin culturing the commercialized human iPS-derived cortical glutamatergic neurons, empty the inlet and outlet reservoirs of the microfluidic device by pipette aspiration, letting only the device channels be filled with medium.
Seed the human iPS cells by adding 10 microliters of 6.5 million human iPS cells per milliliter suspension in the medium, and let the device be under the hood for 15 minutes to allow cells to attach. After 15 minutes, fill both inlet and outlet reservoirs with 50 microliters of day 4 culture medium. Then transfer the device into the incubator to maintain the cells at 37 degrees Celsius and 5% carbon dioxide for 23 days. Replace the medium every 3 to 4 days as described in the text.
To count the cells and assess viability using a standard phase contrast microscope, take microscopic pictures at 4th day, 21st day, and 23rd day. Culture both UW-479 and BT-35 cell lines in DMEM and F-12 glutamax supplemented with 10% fetal bovine serum in a cell culture flask. Maintain cell culture under a controlled environment at 37 degrees Celsius in normoxic conditions throughout the experiments. Observe each cell line to reach 80% confluency.
On day 21 post-culture of glutamatergic neurons, start co-culture by trypsinizing UW-479 and BT-35 cells. Seed the trypsinized UW-479 and BT-35 cells on top of the mature adherent glutamatergic neurons in each dedicated microfluidic device.
Maintain the co-cultures for two days under a controlled environment at 37 degrees Celsius and 5% carbon dioxide with glutamatergic neuron D11 and onward medium. Count pediatric high-grade glioma cells using the microscopic pictures, analyzed with the image analysis software to assess their viability and calculate the percentage of cells.
